3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
170
Gastrointestinal
79
Thoracic
5
Other solid neoplasm
5
Sarcoma
4
Breast
4
Genitourinary
3
Endocrine
3
CNS
2
Plasma cell
1
Other hematologic neoplasm
1
NET
1
Head & Neck
1
Dermatologic
1
Classical hematology
1
Conditions
Neuroendocrine Tumors
377
Carcinoid Tumor
40
Gastro-enteropancreatic neuroendocrine tumor
36
Pancreatic Neoplasms
27
Carcinoma, Neuroendocrine
27
Neoplasms
25
Adenoma, Islet Cell
23
Neoplasm Metastasis
17
Pheochromocytoma
16
Paraganglioma
16
Stomach Neoplasms
15
Neuroblastoma
14
Gastrointestinal Neoplasms
14
Carcinoma, Hepatocellular
12
Thyroid Neoplasms
11
Prostatic Neoplasms
11
Breast Neoplasms
11
Sarcoma
10
Esophageal Neoplasms
10
Colorectal Neoplasms
10
Lung Neoplasms
9
Rectal Neoplasms
8
Gastrointestinal Stromal Tumors
8
Cholangiocarcinoma
8
Carcinoma
8
Brain Neoplasms
8
Anus Neoplasms
8
Liver Neoplasms
7
Colonic Neoplasms
7
Carcinoma, Medullary
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Peritoneal Neoplasms
×
NET
×
Clear all
NCT02012699
2026-05-05
iCaRe2
University of Nebraska
Recruiting
999,999 enrolled